Association of tumor PD-L1 expression and immune biomarkers with clinical activity in patients (pts) with advanced solid tumors treated with nivolumab (anti-PD-1; BMS-936558; ONO-4538).
Grosso, J; Horak, CE; Inzunza, D; Cardona, DM; Simon, JS; Gupta, AK; Sankar, V; Park, J-S; Kollia, G; Taube, JM; Anders, R; Jure-Kunkel, M; Novotny, J; Taylor, CR; Zhang, X; Phillips, T; Simmons, P; Cogswell, J
Volume / Issue
Electronic International Standard Serial Number (EISSN)
International Standard Serial Number (ISSN)
49th Annual Meeting of the American-Society-of-Clinical-Oncology (ASCO)
Conference Start Date
Conference End Date